Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 34-38

  El Shamieh, Said ^a   Herbeth, Bernard ^a   Azimi Nezhad, Mohsen ^a   Benachour, Hamanou ^a   Masson, Christine ^a   Visvikis Siest, Sophie ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Blood pressure genetics; Human formyl peptide receptor 1; Hypertension genetics; SNP

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FPR1 GENE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; BASE SEQUENCE; BLOOD PRESSURE; COHORT STUDIES; DNA PRIMERS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FORMYL PEPTIDE;

EID: 82955234137     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2010.11.038     Document Type: Article

References (32)

1. Hua H., Zhou S., Liu Y., et al. Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. J Hum Hypertens 2005, 19:715-721.
2. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
3. Marteau J.B., Zaiou M., Siest G., Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens 2005, 23:2127-2143.
4. Newton-Cheh C., Johnson T., Gateva V., et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009, 41(3):348-353.
5. Fang Y.J., Deng H.B., Thomas G.N., et al. Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. J Hypertens 2010, 28(6):1203-1209.
6. Jin H.S., Hong K.W., Lim J.E., et al. Genetic variations in the sodium balance-regulating genes ENaC, NEDD4L, NDFIP2 and USP2 influence blood pressure and hypertension. Kidney Blood Press Res 2010, 33:15-23.
7. De C.C., Amiri F., Brassard P., Endemann D.H., Touyz R.M., Schiffrin E.L. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 2005, 25:2106-2113.
8. Savoia C., Schiffrin E.L. Reduction of C-reactive protein and the use of anti-hypertensives. Vasc Health Risk Manage 2007, 3:975-983.
9. Cooper R.S., Luke A., Zhu X., et al. Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 2002, 40:629-633.
10. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008, 40:189-197.
11. Rice T., Rankinen T., Province M.A., et al. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation 2000, 102:1956-1963.
12. Suchindran S., Rivedal D., Guyton J.R., et al. Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study. PLoS Genet 2010, 6:e1000928.
13. Bosse Y., Despres J.P., Chagnon Y.C., et al. Quantitative trait locus on 15q for a metabolic syndrome variable derived from factor analysis. Obesity (Silver Spring) 2007, 15:544-550.
14. Bhattacharya M., Wang J., Ribeiro F.M., et al. Analysis of a missense variant of the human N-formyl peptide receptor that is associated with agonist-independent beta-arrestin association and indices of inflammation. Pharmacogenomics J 2007, 7:190-199.
15. Benachour H., Zaiou M., Herbeth B., et al. Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels. Pharmacogenomics 2009, 10:951-959.
16. Haviland D.L., Borel A.C., Fleischer D.T., Haviland J.C., Wetsel R.A. Structure, 5'-flanking sequence, and chromosome location of the human N-formyl peptide receptor gene. A single-copy gene comprised of two exons on chromosome 19q.13.3 that yields two distinct transcripts by alternative polyadenylation. Biochemistry 1993, 32:4168-4174.
17. Mery J., Brugidou J., Derancourt J. Disulfide bond as peptide-resin linkage in Boc-Bzl SPPS, for potential biochemical applications. Pept Res 1992, 5:233-240.
18. Maney P., Walters J.D. Formylpeptide receptor single nucleotide polymorphism 348T>C and its relationship to polymorphonuclear leukocyte chemotaxis in aggressive periodontitis. J Periodontol 2009, 80:1498-1505.
19. Devaraj S., Singh U., Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009, 20:182-189.
20. Marteau J.B., Sass C., Pfister M., Lambert D., Noyer-Weidner M., Visvikis S. The Leu554Phe polymorphism in the E-selectin gene is associated with blood pressure in overweight people. J Hypertens 2004, 22:305-311.
21. Visvikis-Siest S., Siest G. Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases. Clin Chem Lab Med 2008, 46:733-747.
22. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
23. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
24. Levy D., Ehret G.B., Rice K., et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009, 41:677-687.
25. Niu W., Qi Y., Qian Y., Gao P., Zhu D. The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res 2009, 32:1060-1066.
26. Bode S.M., Kuhn M., Forstermann U. Chemotactic peptide FMLP contracts human coronary arteries via cyclooxygenase products. Am J Physiol 1990, 258:H848-H853.
27. Keitoku M., Kohzuki M., Katoh H., et al. FMLP actions and its binding sites in isolated human coronary arteries. J Mol Cell Cardiol 1997, 29:881-894.
28. Nadar S., Blann A.D., Lip G.Y. Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des 2004, 10:3591-3605.
29. Quehenberger O., Prossnitz E.R., Cavanagh S.L., Cochrane C.G., Ye R.D. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J Biol Chem 1993, 268:18167-18175.
30. Sayed-Tabatabaei F.A., Schut A.F., Arias V.A., et al. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study. J Med Genet 2005, 42:26-30.
31. Zerba K.E., Ferrell R.E., Sing C.F. Complex adaptive systems and human health: the influence of common genotypes of the apolipoprotein E (ApoE) gene polymorphism and age on the relational order within a field of lipid metabolism traits. Hum Genet 2000, 107:466-475.
32. Harrap S.B., Tzourio C., Cambien F., et al. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 2003, 42:297-303.